(Q40446989)

English

Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

object named as

poliovirus

1 reference

based on heuristic

inferred from title

author name string

Bults M

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kemmeren JM

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

van der Maas NA

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

4 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5272-5277

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.017

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.05.017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40446989&oldid=2163957175"